GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer
Clinical trial NCT04206254 · UNKNOWN
Trial details
- NCT number
- NCT04206254
- Sponsor
- Cure&Sure Biotech Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2022-08-05
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.